Litcius/Paper detail

CF and male health: Sexual and reproductive health, hypogonadism, and fertility

Farah Khan, Kelly Mason, Andrea H. Roe, Vin Tangpricha

2021Journal of Clinical & Translational Endocrinology15 citationsDOIOpen Access PDF

Abstract

Over 30,000 people in the United States are diagnosed with cystic fibrosis (CF), and over 50% of those with CF are male. Men with CF face specific and sometimes difficult sexual and reproductive health (SRH) issues, including infertility and hypogonadism. Male infertility affects over 95% of men with CF, with obstructive azoospermia resulting from congenital bilateral absence of the vas deferens being the primary cause of infertility. SRH education for males with CF represents an important opportunity for clinical improvement, as the majority of men with CF know that their disease impacts their fertility, however the depth of this understanding varies significantly. Hypogonadism is a clinical syndrome that affects men with low testosterone level, a common finding among men with CF that has clinical implications and can significantly affect quality of life. Better understanding of SRH attitudes, the prevalence of hypogonadism, and management of infertility in men with CF should remain future research priorities.

Topics & Concepts

MedicineInfertilityAzoospermiaFertilityReproductive healthMale infertilityTestosterone (patch)GynecologyCystic fibrosisInternal medicinePopulationPregnancyEnvironmental healthBiologyGeneticsReproductive Health and TechnologiesOvarian function and disordersCystic Fibrosis Research Advances
CF and male health: Sexual and reproductive health, hypogonadism, and fertility | Litcius